Additional file 1 of Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)

  • Amy Paller (Creator)
  • John C. Browning (Creator)
  • Milos Nikolic (Contributor)
  • Christine Bodemer (Creator)
  • Dedee Murrell (Contributor)
  • Willistine Lenon (Contributor)
  • Eva Krusinska (Creator)
  • Allen Reha (Creator)
  • Hjalmar Lagast (Creator)
  • Jay Barth (Creator)



Additional file 1:. ESSENCE individual patient data. Contains individual de-identified participant data regarding the target wound from the current study.
Date made available2020

Cite this